We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sickle Cell

News List

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ. PharmaSources
May 09, 2024
The first commercial manufacturing run of LYFGENIA – a one-time gene therapy for the treatment of sickle cell disease developed by bluebird bio – was performed at its Allendale, NJ site.
Sickle Cell Plagues Many Black Americans, But There's Hope for Better Treatments drugs
June 21, 2021
It's been more than six months since Brandy Compton last landed in a hospital emergency room.
GBT heads to FDA with sickle cell drug voxelotor pharmaphorum
December 05, 2018
Global Blood Therapeutics (GBT) has persuaded the FDA to accept biomarker data from a phase III trial of sickle cell disease drug voxelotor as part of a filing for accelerated approval.....
Gene Therapy for Sickle Cell Takes Another Step Forward drugs
December 05, 2018
A new gene therapy shows early promise against sickle cell anemia, researchers say.The therapy targets the genetic flaw that causes sickle cell.......
Sickle Cell Trait Tied to Higher Kidney Failure Risk for Blacks drugs.com
March 10, 2017
Black people with a trait for sickle cell anemia appear to have double the risk of kidney failure that requires dialysis, new research suggests.